Mymetics Corp (MYMX)

[Staypositive1]

https://www.news-medical.net/news/20220418/Study-investigates-the-production-of-a-virosome-based-COVID-19-vaccine-candidate.aspx

The production of substantial amounts of stable and high-quality SARS-CoV-2 S proteins is essential for the development of virosomal-based vaccines. Full-length S protein production has been reported using a variety of expression systems, the bulk of which are based on mammalian cells. The insect cell-baculovirus expression vector system (IC-BEVS) is a viable option since it is widely considered a low-cost, scalable manufacturing platform.